ESTRELLA IMMUNOPHARMA, INC. Preferred Stock, Shares Authorized
ESTRELLA IMMUNOPHARMA, INC. (ESLA) had Preferred Stock, Shares Authorized of 10.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-13
- 2026-06-30: Preferred Stock, Shares Authorized 10.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2024-12-31: Preferred Stock, Shares Authorized 10.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 10.00M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 10.00M shares 10-Q · filed 2026-05-18 |
| 2025-12-31 | 10.00M shares 10-Q · filed 2026-08-13 |
| 2024-12-31 | 10.00M shares 10-K · filed 2026-03-18 |
| 2023-06-30 | 1.00M shares 10-Q · filed 2023-08-01 |
| 2023-03-31 | 1.00M shares 10-Q · filed 2023-05-18 |
| 2022-12-31 | 1.00M shares 10-Q · filed 2023-08-01 |
| 2022-09-30 | 1.00M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 1.00M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 1.00M shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 1.00M shares 10-K · filed 2023-03-14 |
| 2021-09-30 | 1.00M shares 10-Q · filed 2021-11-10 |
| 2021-03-31 | 1.00M shares 10-Q · filed 2022-05-16 |
| 2021-01-31 | 1.00M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |